Literature DB >> 18475470

Cyclic-AMP mediated drugs: differential or global reduction of eicosanoid synthesis in the isolated rat lung?

M J Post1, J D Biesebeek, J Wemer, H H Rooij, F J Zijlstra, A J Porsius.   

Abstract

In this study the question was addressed whether cAMP mediated drugs induce a differential reduction of branches of the arachidonic acid metabolism rather than a global reduction of eicosanoid synthesis. The isolated lungs of actively sensitized rats were employed to study prostaglandin and leukotriene release in the presence and absence of the cAMP mediated drugs theophylline, milrinone, sulmazole, isobutyl-methylxanthine and salbutamol. The release of eicosanoids as measured by RIA was predominantly basal and continuous, with a mild antigen induced stimulation only for TXB(2) and the leukotrienes. All drugs reduced eicosanoid release globally. It is concluded that cAMP mediated drugs interfere with arachidonic acid metabolism at a site proximal to the branching into lipoxygenase and cyclo-oxygenase pathways.

Entities:  

Year:  1992        PMID: 18475470      PMCID: PMC2365352          DOI: 10.1155/S0962935192000395

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  18 in total

Review 1.  [Lipoxygenase catalyzation of arachidonic acid metabolism and the effect of its inhibition on anaphylactic reactions].

Authors:  R Grupe
Journal:  Pharmazie       Date:  1986-01       Impact factor: 1.267

2.  Effects of milrinone, sulmazole and theophylline on adenosine enhancement of antigen-induced bronchoconstriction and mediator release in rat isolated lungs.

Authors:  M J Post; J D te Biesebeek; J Wemer; H H van Rooij; A J Porsius
Journal:  Pulm Pharmacol       Date:  1991

3.  Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents.

Authors:  R E Weishaar; S D Burrows; D C Kobylarz; M M Quade; D B Evans
Journal:  Biochem Pharmacol       Date:  1986-03-01       Impact factor: 5.858

4.  Effect of AA-861, a 5-lipoxygenase inhibitor, on leukotriene synthesis in human polymorphonuclear leukocytes and on cyclooxygenase and 12-lipoxygenase activities in human platelets.

Authors:  H Mita; Y Yui; T Shida
Journal:  Allergy       Date:  1986-09       Impact factor: 13.146

5.  Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate.

Authors:  P T Peachell; D W MacGlashan; L M Lichtenstein; R P Schleimer
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

6.  The pharmacologic modulation of mediator release from human basophils.

Authors:  J A Warner; D W MacGlashan; S P Peters; A Kagey-Sobotka; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1988-09       Impact factor: 10.793

7.  Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.

Authors:  V Cohan; J McKenzie-White; M Triggiani; W Massey; A Kagey-Sobotka; L M Lichtenstein
Journal:  Biochem Pharmacol       Date:  1989-12-15       Impact factor: 5.858

8.  Release of arachidonic acid metabolites and histamine from sensitized guinea-pig lung following antigen challenge.

Authors:  N C Turner; C T Dollery
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

9.  Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.

Authors:  B J Undem; P T Peachell; L M Lichtenstein
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

10.  Respiratory responses to leukotrienes and biogenic amines in normal and hyperreactive rats.

Authors:  G Brunet; H Piechuta; R Hamel; G Holme; A W Ford-Hutchinson
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.